The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Low molecular weight heparin (LMWH) use in patients with hematologic malignancy-associated venous thromboembolism (VTE) and severe thrombocytopenia.
 
Nabin Khanal
No Relationships to Disclose
 
Gregory Bociek
No Relationships to Disclose
 
Baojiang Chen
No Relationships to Disclose
 
Julie Vose
Honoraria - Sanofi
Consulting or Advisory Role - Bio Connections
Research Funding - Acerta Pharma (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Janssen Biotech (Inst); Kite, a Gilead company (Inst); Novartis (Inst); Pharmacyclics (Inst); Seagen (Inst); Spectrum Pharmaceuticals (Inst)
 
James O. Armitage
Leadership - Tesaro
Consulting or Advisory Role - Celgene; Conatus; GlaxoSmithKline; Roche; Spectrum Pharmaceuticals; ZIOPHARM Oncology
 
Philip Jay Bierman
No Relationships to Disclose
 
Lori J. Maness
Employment - Allergan (I); Novartis (I)
Research Funding - Celgene (Inst); Cyclacel (Inst)
 
Matthew Alexander Lunning
Consulting or Advisory Role - Alexion Pharmaceuticals; Celgene; Genentech; Gilead Sciences; Juno Therapeutics; Spectrum Pharmaceuticals; TG Therapeutics
 
Krishna Gundabolu
No Relationships to Disclose
 
Vijaya Raj Bhatt
No Relationships to Disclose